Operational Accounting Analyst
IBEX
Operational Accounting Analyst
IBEX
Biotech company: antibodies and gene therapy
This is Work On Site in IBEX Paranaque (SM BF) and on a Night Shift.
What You’ll Do:
Prepare journal entries for cash transactions, ensuring accuracy and compliance with accounting standards.
Perform monthly accruals for operating expenses in collaboration with departments to capture financial obligations promptly.
Record and manage corporate credit card expenses, ensuring adherence to company policies and timely reconciliation.
Manage monthly amortization of prepaid expenses and fixed assets.
Maintain and update monthly financial packages supporting schedules.
Assist in general ledger reconciliations and support audit requests.
What We Look For:
Team-player with excellent interpersonal skills, adept at collaborating with accounting, business, and management teams.
Effective written and verbal communication skills.
Attention to detail in performing accounting tasks and ensuring accuracy.
Ability to adapt quickly to changing environments and proactive approach to problem-solving.
Strong knowledge of US GAAP.
Proficiency in Excel and accounting software/ERP; experience with Netsuite, Brex, FloQast/Numeric is a plus.
Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.
Explore more opportunities at IBEX